|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hohenberger P and Gretschel S: Gastric
cancer. Lancet. 362:305–315. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Polyak K and Hahn WC: Roots and stems:
Stem cells in cancer. Nat Med. 12:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukuda K, Saikawa Y, Ohashi M, Kumagai K,
Kitajima M, Okano H, Matsuzaki Y and Kitagawa Y: Tumor initiating
potential of side population cells in human gastric cancer. Int J
Oncol. 34:1201–1207. 2009.PubMed/NCBI
|
|
5
|
Zhang H, Xi H, Cai A, Xia Q, Wang XX, Lu
C, Zhang Y, Song Z, Wang H, Li Q, et al: Not all side population
cells contain cancer stem-like cells in human gastric cancer cell
lines. Dig Dis Sci. 58:132–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rocco A, Liguori E, Pirozzi G, Tirino V,
Compare D, Franco R, Tatangelo F, Palaia R, D'Armiento FP,
Pollastrone G, et al: CD133 and CD44 cell surface markers do not
identify cancer stem cells in primary human gastric tumors. J Cell
Physiol. 227:2686–2693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chute JP, Muramoto GG, Whitesides J,
Colvin M, Safi R, Chao NJ and McDonnell DP: Inhibition of aldehyde
dehydrogenase and retinoid signaling induces the expansion of human
hematopoietic stem cells. Proc Natl Acad Sci USA. 103:pp.
11707–11712. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Collins SJ: Retinoic acid receptors,
hematopoiesis and leukemogenesis. Curr Opin Hematol. 15:346–351.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Estes BT, Wu AW, Storms RW and Guilak F:
Extended passaging, but not aldehyde dehydrogenase activity,
increases the chondrogenic potential of human adipose-derived adult
stem cells. J Cell Physiol. 209:987–995. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muramoto GG, Russell JL, Safi R, Salter
AB, Himburg HA, Daher P, Meadows SK, Doan P, Storms RW, Chao NJ, et
al: Inhibition of aldehyde dehydrogenase expands hematopoietic stem
cells with radioprotective capacity. Stem Cells. 28:523–534.
2010.PubMed/NCBI
|
|
13
|
Sladek NE: Human aldehyde dehydrogenases:
Potential pathological, pharmacological, and toxicological impact.
J Biochem Mol Toxicol. 17:7–23. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Burger PE, Gupta R, Xiong X, Ontiveros CS,
Salm SN, Moscatelli D and Wilson EL: High aldehyde dehydrogenase
activity: A novel functional marker of murine prostate
stem/progenitor cells. Stem Cells. 27:2220–2228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lingala S, Cui YY, Chen X, Ruebner BH,
Qian XF, Zern MA and Wu J: Immunohistochemical staining of cancer
stem cell markers in hepatocellular carcinoma. Exp Mol Pathol.
89:27–35. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ucar D, Cogle CR, Zucali JR, Ostmark B,
Scott EW, Zori R, Gray BA and Moreb JS: Aldehyde dehydrogenase
activity as a functional marker for lung cancer. Chem Biol
Interact. 178:48–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van den Hoogen C, van der Horst G, Cheung
H, Buijs JT, Lippitt JM, Guzmán-Ramírez N, Hamdy FC, Eaton CL,
Thalmann GN, Cecchini MG, et al: High aldehyde dehydrogenase
activity identifies tumor-initiating and metastasis-initiating
cells in human prostate cancer. Cancer Res. 70:5163–5173. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Deng S, Yang X, Lassus H, Liang S, Kaur S,
Ye Q, Li C, Wang LP, Roby KF, Orsulic S, et al: Distinct expression
levels and patterns of stem cell marker, aldehyde dehydrogenase
isoform 1 (ALDH1), in human epithelial cancers. PLoS One.
5:e102772010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding Y, Liang W and Hu X: Analysis of
heterogenous distribution of different stem characteristic subset
in H22 cells. Armed Police Med. 23:415–418. 2012.
|
|
21
|
Boman BM and Wicha MS: Cancer stem cells:
A step toward the cure. J Clin Oncol. 26:2795–2799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Quante M and Wang TC: Stem cells in
gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol.
6:724–737. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koo BS, Lee SH, Kim JM, Huang S, Kim SH,
Rho YS, Bae WJ, Kang HJ, Kim YS, Moon JH and Lim YC: Oct4 is a
critical regulator of stemness in head and neck squamous carcinoma
cells. Oncogene. 34:2317–2324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tam WL and Ng HH: Sox2: Masterminding the
root of cancer. Cancer Cell. 26:3–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beier F, Beier CP, Aschenbrenner I,
Hildebrandt GC, Brümmendorf TH and Beier D: Identification of
CD133(−)/telomerase(low) progenitor cells in glioblastoma-derived
cancer stem cell lines. Cell Mol Neurobiol. 31:337–343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marcato P, Dean CA, Giacomantonio CA and
Lee PW: Aldehyde dehydrogenase: Its role as a cancer stem cell
marker comes down to the specific isoform. Cell Cycle.
10:1378–1384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beier D, Hau P, Proescholdt M, Lohmeier A,
Wischhusen J, Oefner PJ, Aigner L, Brawanski A, Bogdahn U and Beier
CP: CD133(+) and CD133(−) glioblastoma-derived cancer stem cells
show differential growth characteristics and molecular profiles.
Cancer Res. 67:4010–4015. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Katsuno Y, Ehata S, Yashiro M, Yanagihara
K, Hirakawa K and Miyazono K: Coordinated expression of REG4 and
aldehyde dehydrogenase 1 regulating tumourigenic capacity of
diffuse-type gastric carcinoma-initiating cells is inhibited by
TGF-β. J Pathol. 228:391–404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhi QM, Chen XH, Ji J, Zhang JN, Li JF,
Cai Q, Liu BY, Gu QL, Zhu ZG and Yu YY: Salinomycin can effectively
kill ALDH(high) stem-like cells on gastric cancer. Biomed
Pharmacother. 65:509–515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bosch X: Bone-marrow-derive cells
implicated in gastric cancer. Lancet Oncol. 6:82005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Read TA, Fogarty MP, Markant SL, McLendon
RE, Wei Z, Ellison DW, Febbo PG and Wechsler-Reya RJ:
Identification of CD15 as a marker for tumor-propagating cells in a
mouse model of medulloblastoma. Cancer Cell. 15:135–147. 2009.
View Article : Google Scholar : PubMed/NCBI
|
